B-Cell Malignant Neoplasm — Trials

B-Cell Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,465 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,083
Recruiting: 1,078
Ph III recruiting: 121
Growth YoY: +5.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,167)

clinicaltrialsPublishedShowing 351–363 of 363 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05347641	Penpulimab Combined With RMA Treatment of Primary Diagnosis of Primary Central Nervous System Lymphoma	not yet recruiting	Phase 2	23	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	0	Apr 26, 2022	clinicaltrials
NCT05298293	Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma(EMILY)	not yet recruiting	N/A	160	WepromOTHER	1	Apr 5, 2022